Sucampo Reports Fourth Quarter And Full Year 2016 Financial Results
ROCKVILLE, Md., March 08, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today reported consolidated financial results for the fourth quarter and full year ended December 31, 2016.
Additionally, today Sucampo announced two updates to its executive management team. Andrew Smith, Chief Financial Officer, will be leaving Sucampo to move back to Europe with his family to pursue professional opportunities there. He will remain in his CFO role through March 20 and will thereafter assist in the transition of his responsibilities. Peter Pfreundschuh, CPA will become Sucampo’s new Chief Financial Officer, effective on March 20. Also, effective March 20, Jones “Woody” Bryan, Ph.D. will become Sucampo’s new Senior Vice President of Business Development and Licensing.
Additionally, today Sucampo announced two updates to its executive management team. Andrew Smith, Chief Financial Officer, will be leaving Sucampo to move back to Europe with his family to pursue professional opportunities there. He will remain in his CFO role through March 20 and will thereafter assist in the transition of his responsibilities. Peter Pfreundschuh, CPA will become Sucampo’s new Chief Financial Officer, effective on March 20. Also, effective March 20, Jones “Woody” Bryan, Ph.D. will become Sucampo’s new Senior Vice President of Business Development and Licensing.